Cheng Sohanya Roshan, EVP and Chief Commercial Officer at Karyopharm Therapeutics Inc. ($KPTI), made two open market sales of company shares in the last year, totaling $45,411. Her most recent sale occurred on March 2, 2026. These transactions rank her 10,492nd among 11,678 insiders by sale value, well below the average of $8.6 million per insider across about 6.4 sales. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common Stock | 4604 | $9.41 | 107,317.0000 | 18,343,968 | 4.11% | 0.03% |
| Jan. 31, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 32415 | $0.00 | 111,921.0000 | 17,050,876,000 | 40.77% | 0.00% |
| Oct. 15, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 43650 | $0.00 | 79,506.0000 | 126,240,054 | 121.74% | 0.03% |
| Sept. 12, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 945 | $0.00 | 36,181.0000 | 126,240,054 | 2.68% | 0.00% |
| Sept. 15, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common Stock | 325 | $6.43 | 35,856.0000 | 126,240,054 | 0.90% | 0.00% |
| March 4, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common Stock | 3445 | $6.29 | 34,314.0000 | 126,240,054 | 9.12% | 0.00% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Stock Option (right to buy) | 9166 | $0.00 | 9,166.0000 | 126,240,054 | 9999.99% | 0.01% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 4583 | $0.00 | 37,759.0000 | 126,240,054 | 13.81% | 0.00% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 5416 | $0.00 | 33,176.0000 | 126,240,054 | 19.51% | 0.00% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Stock Option (right to buy) | 10833 | $0.00 | 10,833.0000 | 126,240,054 | 9999.99% | 0.01% |
| Oct. 31, 2024 | Carisma Therapeutics Inc. | $CARM | Cheng Sohanya Roshan | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| Sept. 4, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common Stock | 5356 | $0.72 | 404,051.0000 | 0 | 1.31% | 0.00% |
| Feb. 29, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common | 21840 | $1.17 | 398,618.0000 | 0 | 5.19% | 0.00% |
| March 1, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common | 5109 | $1.20 | 393,509.0000 | 0 | 1.28% | 0.00% |
| Feb. 28, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 198959 | $0.00 | 420,458.0000 | 0 | 89.82% | 0.00% |
| Jan. 24, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 14167 | $0.00 | 221,499.0000 | 0 | 6.83% | 0.00% |
| Sept. 1, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common Stock | 7415 | $1.33 | 204,086.0000 | 0 | 3.51% | 0.00% |
| June 8, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common Stock | 1839 | $2.35 | 211,501.0000 | 0 | 0.86% | 0.00% |
| Feb. 28, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | A | Common Stock | 100000 | $0.00 | 221,926.0000 | 0 | 82.02% | 0.00% |
| March 1, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Cheng Sohanya Roshan | EVP & Chief Commercial Officer | S | Common Stock | 11239 | $3.03 | 210,687.0000 | 0 | 5.06% | 0.00% |